Amplifying the Red-Emission of Upconverting Nanoparticles for Biocompatible Clinically Used Prodrug-Induced Photodynamic Therapy.

Amol Punjabi,Xiang Wu,Amira Tokatli-Apollon,Mahmoud El-Rifai,Hyungseok Lee,Yuanwei Zhang,Chao Wang,Zhuang Liu,Emory M. Chan,Chunying Duan,Gang Han
DOI: https://doi.org/10.1021/nn505051d
IF: 17.1
2014-01-01
ACS Nano
Abstract:A class of biocompatible upconverting nanoparticles (UCNPs) with largely amplified red-emissions was developed. The optimal UCNP shows a high absolute upconversion quantum yield of 3.2% in red-emission, which is 15-fold stronger than the known optimal beta-phase core/shell UCNPs. When conjugated to aminolevulinic acid, a clinically used photodynamic therapy (PDT) prodrug, significant PDT effect in tumor was demonstrated in a deep-tissue (>1.2 cm) setting in vivo at a biocompatible laser power density. Furthermore, we show that our UCNP-PDT system with NIR irradiation outperforms clinically used red light irradiation in a deep tumor setting in vivo. This study marks a major step forward in photodynamic therapy utilizing UCNPs to effectively access deep-set tumors. It also provides an opportunity for the wide application of upconverting red radiation in photonics and biophotonics.
What problem does this paper attempt to address?